Introduction {#S1}
============

*Zymoseptoria tritici* is the causal agent of septoria tritici blotch (STB), the most devastating leaf disease on wheat (*Triticum aestivum*) worldwide ([@B30]; [@B12]). The disease thrives best under humid-temperate conditions and can have several disease cycles per season. STB is present throughout Europe but is the prevalent disease in regions that offer conducive climatic conditions such as Ireland, the United Kingdom, or Northern Germany ([@B20]). The disease incidence of STB decreases toward South and North-East Europe ([@B15]), where STB competes with other leaf blotch diseases, for instance, *Parastagonospora nodorum* and *Pyrenophora tritici-repentis* ([@B18]). Agricultural practices have a direct impact on disease severity. Whereas early sowing of winter wheat and minimum tillage favor epidemics of STB, the use of varietal resistance and a delay of sowing help mitigate the primary inoculum at the beginning of the season, and thus disease severity in the following year. Despite recent achievements in breeding and a focus on non-chemical practices ([@B16]; [@B6]), STB control is highly reliant on frequent and timely applications of fungicides. Yield losses can amount to up to 30--50% if the disease is not efficiently controlled ([@B20]). Currently, three main fungicide groups are available for STB disease control: (1) quinone outside inhibitors (QoI), (2) 14α-demethylase inhibitors (DMI), and (3) succinate dehydrogenase inhibitors (SDHI). Compounds of those three groups have been used for many years now and have efficiently reduced the impact of STB. Nevertheless, field efficacies of many active ingredients belonging to those groups have reduced due to fungicide resistance in recent years ([@B4]; [@B24]).

Population genetic studies based on mark--release--recapture experiments conducted in the field indicated that pathogen populations might change significantly over a single growing season in response to host genotypes ([@B46]). The development of fungicide resistance has been attributed to several molecular mechanisms, including alterations and overexpression of the target-site and the pathogen's ability to lower the amount of fungicide in the cell through overexpression of efflux pumps ([@B9]). Resistance to all single-site fungicides is present in most *Z. tritici* populations, to which degree, however, may greatly vary locally. Mutations in the target gene of a fungicide are the most common mechanisms of fungicide resistance in *Z. tritici* ([@B29]). Fungicide resistance can occur in a disruptive manner or stepwise.

Resistance to QoI fungicides arose promptly after the introduction of this mode of action (MoA) in the early 2000s, associated with point mutations in the mitochondrial *cytochrome b* gene (*cytb*). Isolates carrying F129L or G137R express moderate (partial) resistance and are comparably somewhat sporadic in *Z. tritici* populations. In contrast, point mutation G143A confers full resistance and dominates in current *Z. tritici* populations. Consequently, QoI fungicides are no longer effective against *Z. tritici* in most European countries ([@B13]; [@B38]).

Since their introduction in the 1970s, azoles have become essential components of plant disease control in the fields because of their wide-ranging efficacy against many agriculturally important diseases ([@B36]). Prolonged and intensive usage of agricultural azole fungicides in crop protection has been the main driver in the emergence of azole resistance in fungi. Several molecular mechanisms play a role in reduced azole sensitivity. The most common mechanism is alterations in the *CYP51* gene leading to amino acid changes of the CYP51 enzyme. To date, over 30 different amino acid alterations (substitutions and deletions) have been identified in the CYP51 protein of modern *Z. tritici* populations, and over 30 different genotypes have been registered so far ([@B9]; [@B19]). Mutations leading to exchanges D134G, V136A/C/G, A379G, I381V, S524T, and deletions or mutations at nucleotides coding for amino acids 459--461 are currently claimed to have the highest effect on the sensitivity to azoles ([@B10]; [@B44]). The emergence of S524T in field populations of *Z. tritici* has caused particular concern as prothioconazole, along with epoxiconazole, is one of the two remaining azole fungicides still highly effective against STB ([@B10]). Mutations can occur in combination, and the presence or absence of a single mutation can render an isolates resistant. Furthermore, [@B8] described an insertion of 120 bp in the *CYP51* gene that leads to overexpression of the gene and, consequently, an increased azole tolerance.

After the rapid development of resistance against QoI and DMI fungicides, a newer generation of SDHI for cereal diseases was launched in the last few years that are very effective in controlling STB ([@B39]). Several target mutations have already been described both in the laboratory and in the field, which can lead to SDHI resistance. For example, C-T79N can be found alone or in combination with C-I29V or with both C-N33T, C-N34T, and C-H152R ([@B11]). Several point mutations in the *Sdh* subunits have been associated with high EC~50~ values: B-N225I/T, B-H267X, B-T268I, B-I269V, C-N86S, C-N86K, C-T79N, C-T79I, C-W80S, C-G90R, and C-H152R ([@B33]). Unlike the *CYP51* mutations, haplotypes with more than one *Sdh* mutation have rarely occurred in nature yet.

In addition to the target-site-specific mutations, [@B27] described a third mechanism, rendering *Z. tritici* phenotypes resistant to several MoA, a phenotype considered as multi-drug-resistant (MDR). Those strains were later associated with an enhanced active fungicide efflux ([@B32]). Three different types of inserts in the promoter region of the "major facilitator gene" (*MFS1*) were identified in MDR field strains leading to overexpression of this gene. In the current *Z. tritici* population, the number of MDR strains are increasing and are frequently found in Western Europe ([@B24]). In Northern Europe, strains harboring one of the inserts are present, but in low frequency ([@B18]).

In Baltic countries, a wider range of active ingredients in fungicides is available than in other Northern European countries. Over a long period now, the Baltic *Z. tritici* populations have been exposed to different MoA; however, a systematic resistance testing of *Z. tritici* has not been carried out. The overall objective of this study was to describe the current fungicide resistance situation of *Z. tritici* in the Baltic region.

Materials and Methods {#S2}
=====================

Isolate Collection {#S2.SS1}
------------------

A total of 73 single pycnidium isolates of *Z. tritici* were produced, 29 of which from Estonia, 4 from Latvia, 30 from Lithuania, and 10 from Finland in 2018. Leaf samples were collected from the upper two leaves layers, mainly from untreated plots. The leaves were placed in a petri dish on moist filter paper without prior surface sterilization. After 24 h incubation at room temperature, cirrhi from single pycnidia were transferred onto potato dextrose agar, amended with 0.01% streptomycin, using a sterile needle. Single spore colonies appeared after 6 days of incubation at 20°C and 12 h white light/12 darkness. Spores were conserved in 20% glycerol at −80°C.

Determination of EC~50~ {#S2.SS2}
-----------------------

Spore suspensions were produced by scraping off 6-day-old *Z. tritici* spores and transferring them into sterile, demineralized water. The suspensions were vortex-mixed in 10 ml Falcon tubes for 10 min for homogenization. Spore concentrations were adjusted to 2.5 × 10^4^ spores ml^--1^. Epoxiconazole, tebuconazole, and prothioconazole-desthio (all Sigma-Aldrich, St. Louis, MO, United States) were mixed separately with 2 × potato dextrose broth to obtain the following final microtiter plate fungicide concentrations (mg l^--1^): 10, 3.3, 1.0, 0.3, 0.1, 0.03, 0.01, and 0 for epoxiconazole and 90, 30, 10, 3.3, 1.0, 0.3, 0.1, and 0 for prothioconazole-desthio and tebuconazole. One hundred microliter of spore suspension and 100 μl fungicide solution were added to a nunc^TM^ 96-deep well microtiter plate (Thermo Fisher Scientific, Roskilde, Denmark). Technical duplicates of each isolate were performed on the same plate, and Dutch isolate IPO323 (azole-sensitive) and the Irish isolate OP15.1 (moderately azole-resistant) were included as references. Microtiter plates were wrapped in aluminum foil and incubated in the dark at 20°C for 6 days. The plates were visually checked for bacterial and fungal contamination before the analysis in an iMark^TM^ Microplate Absorbance Reader (Bio-Rad, Copenhagen, Denmark) at wavelength 620 nm. The fungicide dose reducing growth in the microplate wells by 50% (EC~50~) was determined by non-linear regression (curve-fit) using GraphPad Prism (GraphPad Software, La Jolla, CA, United States). Resistance factors were calculated based on the reference EC~50~ values for IPO323. The EC~50~ values for fluxapyroxad (Sigma-Aldrich, St. Louis, MO, United States) were determined correspondingly using a 10-fold dilution series starting at 3 ppm.

Sequencing of Target Site Mutations {#S2.SS3}
-----------------------------------

All isolates were tested for target mutations for azole, SDHI, and strobilurin fungicides. The presence of *CYP51* mutations L50S, D134G, V136A/C, G379A, I381V, and S524T and *cytb* mutation G143A conferring strobilurin resistance were determined using Kompetitive Allele Specific PCR (KASP) (LGC Genomics, Teddington, United Kingdom) genotyping previously described by [@B25]. All reactions were carried out in an Applied Biosystems Viia^TM^ 7 Real-time PCR system machine (Thermo Fisher Scientific, Denmark) according to the manufacturer's protocol.

Sequences of the *Sdh* sub-units B, C, D were obtained using the protocol by [@B33]. PCR reactions were performed utilizing the GoTaq Flexi DNA Polymerase kit (Promega, Madison, WI, United States) in a 25 μl volume containing 10.9 μl Gibco water, 5.0 μl 5× GoTaqFlexi PCR buffer, 1.5 mM MgCl~2~, 125 μM of each dNTP, and forward primer and reverse primer (both 10 μM), 1 unit GoTaqFlexi DNA polymerase (Promega, Madison, WI, United States), and 1.0 μl DNA (approximately 5 ng μl^--1^). The amplification was performed using the following conditions: 95°C for 5 min, followed by 35 cycles of 95°C for 30 s, 62°C for 30 s, 72°C for 30 s, with a final extension of 7 min at 72°C. The PCR products were purified and sequenced by Macrogen Europe BV (Amsterdam, Netherlands). Sequence alignment was performed using CLC WorkBench 7 (QIAGEN, Aarhus, Denmark).

Testing for Potential Overexpression of the *CYP51* and *MFS1* Genes {#S2.SS4}
--------------------------------------------------------------------

All isolates were investigated for the presence of inserts in the *CYP51* promoter region, conferring CYP51 overexpression ([@B8]). PCR reactions were performed using the GoTaq Flexi DNA Polymerase kit (Promega, Madison, WI, United States) in a 25 μl volume containing 10.9 μl Gibco water, 5.0 μl 5× GoTaqFlexi PCR buffer, 1.5 mM MgCl~2~, 125 μM of each dNTP, and forward primer Mg51-proF and reverse primer Mg51-seqR (both 10 μM), 1 unit GoTaqFlexi DNA polymerase, and 1.0 μl DNA (approximately 5 ng μl^--1^). The PCR conditions were 95°C for 5 min, followed by 35 cycles of 95°C for 30 s, 62°C for 30 s, 72°C for 30 s, with a final extension of 7 min at 72°C.

To screen for inserts in the promoter region of the *MFS1* gene, PCR reactions were performed using primer pair MFS_2F/MFS_4R designed by [@B32]. PCR reactions were set up in a 25 μl volume containing 19.75 μl Gibco water, 2.0 μl buffer, 1.25 μl dNTP mix forward primer and reverse primer (both 10 μM), and 1.0 μl DNA. The reactions were run according to the following protocol: 35 cycles of 95°C for 30 s, 62°C for 30 s, 72°C for 30 s, with a final extension of 7 min at 72°C.

All PCR reactions in this study were performed in an Applied Biosystems 2720 Thermal Cycler. The samples were loaded on a 1.5% agarose gel containing SYBR^®^ stain (Thermo Fisher Scientific, Denmark) and run for 45 min at 100 V.

*MFS1* Insert Sequence Analysis {#S2.SS5}
-------------------------------

The PCR fragment of strain 18-Zt-EE-06-03 obtained with the primer couple MFS_2F/MFS_4R was Sanger sequenced (Eurofins Genomics) with the same primers and the additional sequencing primer Estland-sample_LF (5′ TGGTGTTTCCATGCGTTTAG 3′). Output sequences were trimmed and assembled using the CodonCode Aligner software v9.0.1 (CodonCode Corp., Centerville, MA, United States). The insert sequence and surrounding *MFS1* promoter sequence have been deposited at Genbank under accession number [MN813065](MN813065). The insert sequence was used for database searches using blastn, blastx ([@B1]) at NCBI^[1](#footnote1){ref-type="fn"}^ against non-redundant databases. The peptide translation of the longest ORF was analyzed using PSI-blast and DELTA-blast at NCBI. Inverted repeats were identified using the einverted algorithm^[2](#footnote2){ref-type="fn"}^. Searches for annotated transposable elements (TE) were performed as blastn-searches against the TE database Repbase ([@B23]).

Results {#S3}
=======

Azole Sensitivity Testing and CYP51 Sequence Analysis of Baltic *Z. tritici* Strains {#S3.SS1}
------------------------------------------------------------------------------------

Seventy-three *Z. triti*ci isolates were sampled in Estonia (29), Latvia (4), Lithuania (30), and Finland (10) during 2018. The individual pycnidium isolates were investigated for sensitivity to epoxiconazole, prothioconazole-desthio, and tebuconazole in order to calculate EC~50~ value for each isolate. In 2018, the average EC~50~ value for epoxiconazole was 1.73 ppm, with single isolates ranging from 0.35 to 8.29 ppm. The average EC~50~ was highest in Estonia (2.19 ppm) but lower in Latvia (1.97 ppm), Lithuania (1.67 ppm), and Finland (1.04 ppm). The average resistance factor (RF; mean EC~50~ of the resistant population)/(mean EC~50~ of the reference isolate IPO323) for epoxiconazole was 69 (reference isolate IPO323: 0.02--0.03 ppm) ranging from 42 in Finland to 87 in Estonia, 67 in Lithuania, and 79 in Latvia ([Table 1](#T1){ref-type="table"}). The average EC~50~ value for prothioconazole-desthio was 0.14 ppm, with single isolates ranging from 0.01 to 2.0 ppm. The average EC~50~ was highest in Lithuania (0.24 ppm) but lowest Estonia (0.14 ppm), Latvia (0.13 ppm), and Finland (0.06 ppm). The average RF for prothioconazole-desthio was 14 (reference isolate IPO323: 0.01 ppm) ranging from 6 in Finland to 24 in Lithuania, 13 in Latvia, and 11 in Estonia. The average EC50 value for tebuconazole was 8.45 ppm, with single isolates ranging from 0.13 to 59 ppm. The average EC~50~ was highest in Estonia 18.23 ppm (0.13--59 ppm) but lower Lithuania 9.18 ppm (0.8--48 ppm), Finland 5.13 ppm (0.3--18.2 ppm) and Latvia 1.25 ppm (0.34--2.4 ppm). The average RF for tebuconazole was 211 (reference isolate IPO323: 0.041 ppm) ranging from 31 in Latvia to 456 in Estonia, 128 in Finland, and 230 in Lithuania ([Table 1](#T1){ref-type="table"}).

###### 

Summary of average EC~50~ (ppm) values and resistance factors (RF)^a^ for epoxiconazole, prothioconazole-desthio, and tebuconazole assessed for *Z. tritici* in Estonia, Finland, Latvia, and Lithuania.

  **Country**            **Epoxiconazole**   **Prothioconazole-desthio**   **Tebuconazole**                
  ---------------------- ------------------- ----------------------------- ------------------ ---- ------- -----
  Estonia (*n* = 29)     2.19                87                            0.14               11   18.23   456
  Finland (*n* = 10)     1.04                42                            0.06               6    5.13    128
  Lithuania (*n* = 30)   1.67                67                            0.24               24   9.18    230
  Latvia (*n* = 4)       1.97                79                            0.13               13   1.25    31
  Average                1.73                69                            0.14               14   8.45    211
  Reference IPO323       0.02--0.03                                        0.01                    0.04    

a

Resistance factor: (mean EC

50

of resistant population)/(mean EC

50

of reference isolate IPO323).

Several point mutations in the *CYP51* gene have been associated with elevated EC~50~ values for azoles. Sequencing analysis of all selected isolates showed the presence of *CYP51* point mutations D134G, V136A/C, I381V, and S524T in *Z. tritici*, associated with increased fungicide resistance to the currently widely used azoles ([Figure 1](#F1){ref-type="fig"}). Mutation I381V continued to dominate throughout the region and is present in frequencies of 96--100%, except for Latvia, where this mutation was present at a lower rate, 25%, respectively. Grouping of *Z. tritici* isolates from different Baltic countries revealed 14 different genotypes ([Table 2](#T2){ref-type="table"}). The substitution S524T, found in Estonian and Lithuanian samples, was always combined with V136A and I381V and in some isolates, these three substitutions were combined with L50S and D134G ([Table 2](#T2){ref-type="table"}). The frequencies for mutations L50S, D134G, V136A/C, and A379G, all of which have recently emerged in the European *Z. tritici* population, varied considerably. The only single substitutions of CYP51 found in the in Baltic-Finnish isolates were V136A and I381V.

![*CYP51* mutation frequencies (%) in *Z. tritici* populations from Estonia, Finland, Latvia, and Lithuania in 2018.](fpls-11-00385-g001){#F1}

###### 

Amino acid polymorphisms in the *CYP51* gene from *Z. tritici* field isolates collected in the Finnish-Baltic region in 2018.

  **Origin**       **Position of amino acid polymorphism**                   
  ---------------- ----------------------------------------- --- --- --- --- ---
  EE, LT           S                                         G   V   A   V   T
  EE               S                                         D   A   A   V   T
  LT               S                                         G   A   A   V   T
  EE, LT           L                                         D   A   A   V   T
  EE, FI           S                                         G   A   A   V   S
  LT               L                                         G   A   A   V   S
  EE, LT           S                                         D   V   G   V   S
  LT. FI           L                                         G   A   A   V   S
  EE, FI, LT, LV   L                                         D   V   G   V   S
  FI               L                                         G   V   A   V   S
  EE, FI           S                                         D   V   A   V   S
  LV               L                                         G   A   A   V   S
  EE, FI, LT       L                                         D   V   A   V   S
  LV               L                                         D   A   A   I   S
                                                                             

Identification of G143A Mutations *Z. tritici* Strains Isolated in Finnish-Baltic Region {#S3.SS2}
----------------------------------------------------------------------------------------

So far, G143A has been found in all isolates with high resistance levels to strobilurins ([@B13]; [@B38]). All the isolates collected during 2018 were subsequently screened using the qPCR assay. The allele A143 was found in 41 of the 73 isolates (56%; [Table 3](#T3){ref-type="table"}). Analysis of the results showed that the frequencies of this mutation were at a high level throughout the Finnish-Baltic region: Estonia, Finland, Latvia (50%), and Lithuania (73%) ([Table 3](#T3){ref-type="table"}).

###### 

Frequency of G143A mutations in *Z. tritici* collected in 2018 across the Baltic-Finnish region.

  **Country**   **Frequency of G143A mutation**        
  ------------- --------------------------------- ---- ----
  Estonia       14                                14   50
  Finland       5                                 5    50
  Latvia        2                                 2    50
  Lithuania     22                                8    73

Sensitivity of Baltic-Finnish Isolates to Fluxapyroxad {#S3.SS3}
------------------------------------------------------

The sensitivity profiles of all 73 single-spore isolates from the Finnish-Baltic region to SDHI fluxapyroxad were measured. The average EC~50~ value for fluxapyroxad was 0.2 ppm, with single isolates ranging from 0.07 to 0.33 ppm. The average EC~50~ was highest in Lithuania 0.33 ppm (0.01--1.00 ppm) but lower in Latvia 0.23 (0.05--0.49 ppm), Estonia 0.18 ppm (0.04--1.12 ppm), and Finland 0.07 ppm (0.03--0.27 ppm; [Table 4](#T4){ref-type="table"}). The average RF for fluxapyroxad was 7 (reference isolate IPO323: 0.03 ppm) ranging from 11 in Lithuania to 8 in Latvia, 6 in Estonia, and 2 in Finland ([Table 4](#T4){ref-type="table"}). Several point mutations in the *Sdh* subunits B, C, and D have been associated with elevated EC~50~ values. In this study, we did not detect any alterations in the *Sdh* subunits.

###### 

Summary of measured EC~50~ (ppm) values and resistance factors (RF) for fluxapyroxad assessed for *Z. tritici* in Estonia, Finland, Latvia, and Lithuania.

  **Country**            **Fluxapyroxad**   
  ---------------------- ------------------ ----
  Estonia (*n* = 29)     0.18               6
  Finland (*n* = 10)     0.07               2
  Lithuania (*n* = 30)   0.23               8
  Latvia (*n* = 4)       0.33               11
  Average                0.20               7
  Reference IPO323       0.03               

Insertion in the *CYP51* Promoter Region {#S3.SS4}
----------------------------------------

From the Finnish-Baltic region, in 18% of all isolates tested a PCR fragment of 334 bp was detected, indicating that these isolates had no insert (wild-type). From four Estonian isolates (14%), one Latvian isolate (25%), and five Lithuanian isolates (17%), a PCR fragment of approximately 450 bp was amplified, indicating that these isolates had 120 bp insert in the promoter region as described by [@B8]. In Estonian, Finnish, Latvian, and Lithuanian isolates, the 866 bp insert, previously described by [@B7],[@B32], and [@B24], was present in 65--75% ([Figure 2](#F2){ref-type="fig"}).

![Promoter inserts frequency (%) of the *CYP51* gene of Estonian, Finnish, Latvian, and Lithuanian *Z. tritici* strains.](fpls-11-00385-g002){#F2}

Detection of Inserts in the *MFS1* Promoter as Potential Drivers of Multi-Drug Resistance {#S3.SS5}
-----------------------------------------------------------------------------------------

We then searched for potential MDR isolates as described by [@B32]. We, therefore, amplified in all *Z. tritici* isolates a promoter fragment of the *MFS1* gene encoding a membrane transporter of the major facilitator superfamily ([@B34], [@B35]) involved in MDR in *Z. tritici* field strains ([@B32], [@B31]), using the primer couple published by [@B32]. All but one isolate gave rise to the "sensitive" allele of 500 bp. Only isolate 18-ZT-EE-06-03 led to an amplicon of \>2 kb. Sensitivity assays to the squalene epoxidase inhibitors tolnaftate and terbinafine, used as monitoring molecules to detect MDR ([@B27]), revealed that the 18-Zt-EE-06-03 isolate was not resistant to these molecules and therefore potentially not MDR (data not shown).

Sequence analysis of the promoter amplicon revealed an 1884 bp previously unknown insert at position-194 relative to the Start codon ([Figure 3](#F3){ref-type="fig"}). Blastn searches at Genbank revealed that the sequence was highly similar to sequences found in other *Z. tritici* strains (three copies in strains 3D7 and 1A5, one copy in 3D1, and IPO323, respectively), although at other locations. Blastx searches at Genbank revealed a conserved protein domain, known as DDE superfamily endonuclease involved in DNA transposition. We identified an open-reading-frame (ORF) of 1032 bp (343 amino acids) transcribed from the complementary strand with substantial sequence similarity (\>40% identity according to the algorithm used) to transposases as revealed by DELTA-blast ([@B5]) and PSI-blast ([@B2]) searches at NCBI. We then searched the Repbase database of eukaryotic TEs for similarity to any known TE, without success. Manual and *in silico* analysis of the promoter insert sequence, following the guidelines proposed by [@B43] for TE analysis, allowed us to detect the target site duplication (TSD) 5′ TA/CTCGTG 3′, inversed at the opposite end, and a rather long terminal inverted repeat of 62 bp (with four mismatches). In recent work, [@B3] have annotated TEs in the *Z. tritici* pangenome. Sequences highly similar to the MFS1 promoter insert of strain 18-Zt-EE-06-03 were annotated as DTT_Birute transposon family of the *Tc1-Mariner* superfamily, class II DNA transposons (Oggenfuss and Croll, personal communication) according to the nomenclature proposed by [@B43]. The sequence was uploaded to GenBank under accession number [MN813065](MN813065).

![Promotor structure of the *MFS1 locus* in strain 18-ZT-EE-06-03. The promotor insert with its location is indicated by the blue triangle. The inverted target site duplications at the insertion site are indicated in red in 5′--3′ direction. A terminal inverted repeat (TIR) sequence of 62 bp as detected by the "inverted" algorithm is indicated by the violet boxes. An ORF of 1032 bp with strong similarity to transposases is indicated by the green arrow.](fpls-11-00385-g003){#F3}

Discussion {#S4}
==========

The recent decline in field efficacy against STB of azole and SDHI fungicides in Northwestern Europe ([@B18]; [@B24]) led us to investigate the present resistance situation of *Z. tritici* in the Finnish-Baltic region. Up to now, azoles and SDHI have provided sufficient control in Estonia, Latvia, and Lithuania. In our investigation, we tested single pycnidium isolates of *Z. tritici in vitro* for their sensitivity toward commonly used azoles for STB control. The results confirmed different levels of sensitivity for all isolates tested for the different azoles. The EC~50~ values for epoxiconazole were highest in Estonia and prothioconazole-desthio in Lithuania ([Table 1](#T1){ref-type="table"}). The average EC~50~ values for epoxiconazole were \>1 ppm throughout the region, indicating a general adaption of the Baltic-Finnish *Z. tritici* population to this active ingredient. Compared to the resistance status in 2014, described by [@B18], an apparent sensitivity shift has occurred over the last four years ([Table 5](#T5){ref-type="table"}). The resistance factors for prothioconazole-desthio were lower than for epoxiconazole and indicated a moderate adaption.

###### 

Comparison of average EC~50~ values (ppm) and resistance factors (RF) of epoxiconazole assessed for *Z. tritici* in Estonia, Finland, Latvia, and Lithuania in 2014 and 2018.

  **Country**   **Epoxiconazole**               
  ------------- ------------------- ------ ---- ----
  Estonia       0.07                2.19   7    87
  Finland       0.23                1.04   4    42
  Lithuania     0.14                1.67   15   67
  Latvia        0.16                1.97   17   79
  Average       0.15                1.73   16   69

The resistance level of tebuconazole was significantly higher for all isolates tested ([Table 1](#T1){ref-type="table"}). Resistance to tebuconazole has been widely spread in Europe and attributed to *CYP51* mutation I381V ([@B14]). The field performance of tebuconazole has thus been considerably low in many European regions. [@B21] described, however, a regional variation for some countries where tebuconazole still performed well. Also, in the Baltic countries, tebuconazole is still widely used and provides reasonable STB control in the field. The results from this study, though, suggested an adaption to a more tebuconazole-resistant *Z. tritici* population. Compared to other countries, this adaption has reached the Finnish-Baltic region with a delay.

The first cases of fungicide-adapted strains are usually found in "high-risk" areas with conducive climatic conditions for a fungus. High disease incidence and high inputs of fungicide to control the pathogen lead to a rapid selection for resistant strains ([@B22]). Examples for azole resistance development of *Z. tritici* at different paces have been observed in Northwestern Europe and France ([@B18]; [@B15]). In the United States and Australia, where fungicide inputs are traditionally lower than in Europe, the adaption of *Z. tritici* to azoles is first now occurring ([@B40]; [@B28]). In Europe, [@B21] showed that a gradient of fungicide resistance from west to east exists. Resistance issues of epoxiconazole and prothioconazole were reported in the United Kingdom from 2008. In Denmark, resistance to epoxiconazole and prothioconazole, both measured as the decline in field efficacy and *in vitro*, had not occurred before 2015. From 2015, field efficacy for both compounds declined noticeably, coinciding with a drastic increase in the frequency of azole-resistant isolates ([@B18]). The recent appearance of increasingly more azole-resistant isolates in the Baltic area suggests a similar trend, as seen in Denmark and Sweden. Intensified fungicide monitoring activities for *Z. tritici* in the region will be carried in the coming year to follow up on this development. The development appears to be consistent in all three Baltic countries and Finland. In a study, [@B42] compared the *Z. tritici* isolates from the different Scandinavian and Baltic countries in 2014 using AFLP markers, and found two distinct populations: a Danish-Swedish and a Baltic-Finnish. The existence of a single Baltic-Finnish *Z. tritici* population might explain a delayed and simultaneous change in fungicide sensitivity.

Several studies have previously demonstrated that applications of fungicide select for mutations both *in vitro* and in the field ([@B26]; [@B44]; [@B17]). Several studies identified single nucleotide polymorphisms in the *CYP51* gene being the primary force behind azole resistance ([@B10]; [@B27]; [@B9]). A specific combination of the *CYP51* mutations determines the final sensitivity of an individual *Z. tritici* strain. However, as not all alterations are equally important, single frequencies of specific *CYP51* mutations give a proper indication for the selection status of a population.

In this study, we investigated single pycnidium *Z. tritici* isolates sampled in the Finnish-Baltic region in 2018 for the occurrence of most important *CYP51* mutations D134G, V136A/C, A379G, I381V, and S524T ([@B26]; [@B9]) to determine the resistance stage of this population. The leaf samples derived primarily from untreated plots to determine fungicide resistance in the absence of fungicides. I381V remains the most predominant mutation in all Baltic countries ([@B18]; [@B42]); only in Latvia, this mutation was present at low levels in 2018 ([Figure 1](#F1){ref-type="fig"} and [Table 6](#T6){ref-type="table"}). Point mutation A379G, known to occur exclusively in combination with I381V, was present in all countries and showed an minor increase compared to 2014 ([@B18]). D134G and V136A, which were absent or present at a low level in the Finnish-Baltic region in 2014, have increased over five years up to a level of 50% in Lithuania ([Figure 1](#F1){ref-type="fig"} and [Table 6](#T6){ref-type="table"}). V136C and S524T, which, especially in combination, have a significant impact on azole sensitivity ([@B10]), were present in Estonia and Lithuania at low levels of less than 10% ([Figure 1](#F1){ref-type="fig"}). All the isolates tested from the Finnish-Baltic region had at least one mutation in the *CYP51* gene. The *Z. tritici* wild-type, which was still present in 2014, seems thus to be replaced ([@B18]). The evolution of *CYP51* mutations in the Baltic-Finnish *Z. tritici* population starts more to resemble that in Denmark and Sweden ([@B18]; [@B42]). This development is an indication that the evolution of the *CYP51* gene has reached the Northeastern parts of Europe. This assumption is supported by the fact that only 2 of 14 haplotypes found in the Finnish-Baltic region showed a single mutation in the *CYP51* gene ([Table 2](#T2){ref-type="table"}). In addition to target site mutation, the overexpression of the target gene can confer tolerance toward fungicides. In the Baltic *Z. tritici* population, we detected the 120 bp insertion in the promoter region of the *CYP51* gene for the first time ([Figure 2](#F2){ref-type="fig"}). It was first described by [@B8] and associated with an overexpression of the *CYP51* gene, increasing a strain's tolerance to azole fungicides. This insertion has been detected in several *CYP51* haplotypes ([@B19]), and has increased in frequency in the European *Z. tritici* population in recent years. Presumably, due to a fitness advantage in the presence of fungicides. Furthermore, the 866 bp insertion in the *CYP51* promoter region was found at high frequencies (\>70%) in all countries ([@B7]). This high number is consistent with studies of other European *Z. tritici* populations ([@B18]; [@B24]). [@B24] found an overexpression of the *CYP51* gene in the presence of epoxiconazole in a specific CYP51 background. However, the impact of this insert on the *CYP51* gene needs to be further investigated to be entirely understood.

###### 

*CYP51* mutations frequencies (%) in *Zymoseptoria tritici* samples from the Finnish-Baltic region in 2014 and 2018.

  **Country**   **Year**   **Mutations (%)**                       
  ------------- ---------- ------------------- ---- --- ---- ----- ----
  Estonia       2014       0                   0    0   0    100   0
                2018       19                  8    3   16   98    8
  Finland       2014       17                  8    8   10   77    5
                2018       30                  20   0   28   100   0
  Lithuania     2014       10                  12   5   12   80    5
                2018       20                  20   0   23   98    10
  Latvia        2014       0                   5    0   10   95    0
                2018       50                  50   6   25   25    0

The primary mechanism of decreased sensitivity against strobilurin class fungicides is the alteration of *cytb* at location G143 (mutation G143A). Resistance toward QoI fungicide occurred at least four times simultaneously in Europe and spread rapidly throughout Europe ([@B13]; [@B41]). Our results showed that G143A has increased over five years, reaching over 70% in Lithuania and 50% in Estonia (not detected in Estonia in 2014) and Latvia. Only in Finland, the frequency of this mutation decreased slightly during this period ([Table 3](#T3){ref-type="table"}). G143A mutants are known to have a high level of cross-resistance between different strobilurins. Even though not recommended anymore against STB, QoI fungicides remain effective against other diseases (rust diseases) and are therefore still applied in the field. The continuous use of any strobilurin creates favorable conditions for the further spreading of *Z. tritici* strains carrying G143A.

Field isolates with reduced sensitivity to SDHI fungicide commonly carry a single amino acid substitution in one of the four *Sdh* subunits ([@B37]). In this study, the average EC~50~ values varied in the region from 0.07 to 0.33 ppm. Only a few strains surpassed the EC~50~ of 1.0 ppm. In Ireland, reduced field efficacy of SDHI was especially correlated with a high frequency of C-T79N (Kildea, personal communication). In Scandinavia, only rare cases of C-T79N and C-N86S are reported each year. No *Sdh* mutations were detected in the isolate collection tested in this study. *Sdh* mutations are, thus, not drivers for increased tolerance in these isolates. These findings are similar to the results presented by [@B45]. The appearance of resistant isolates in the populations can be the result of *in planta* degradation of SDHI caused either by the plant and/or the fungus itself. This study shows that adapted *Z. tritici* strains exist in the fields and should be considered a potential risk for the future.

Finally, we did not detect any MDR strain among our collected isolates. Interestingly, using the PCR diagnostic test to detect MDR strains as proposed by [@B32], we found one strain that harbors a previously unknown insertion in the *MFS1* promoter. Since this strain does not display an MDR phenotype, we suspect that it does not overexpress the *MFS1* gene. It is intriguing to notice that this is the fourth type of repeated insert detected in the *MFS1* promoter. While the three other insertions are or may be putative relics of TE driving *MFS1* overexpression, the insertion of a whole transposon observed in strain 18-Zt-EE-06-03 probably abolishes transcription of *MFS1*, especially since the transcription of the transposase is from the opposite strand. The frequent presence of repeated elements in the *MFS1*, but also in the *CYP51* promoter ([@B7]; [@B8]; [@B24]) raises the question of promoter plasticity. Additional population genomic studies are required to clarify if these types of the insert are distributed uniformly over the entire *Z. tritici* genome, or if some genomic regions, such as specific promoters, are preferred. Moreover, the role of fungicide selection pressure in promoter insertions remains to be evaluated.

Conclusion {#S5}
==========

In conclusion, the results presented in this study show an increase in EC~50~ values of the Baltic-Finnish *Z. tritici* population of commonly used azoles. We showed that the frequencies of key *CYP51* mutations and G143A of the Baltic-Finnish *Z. tritici* population have increased from 2014 to 2018. The results indicate that the same development has taken place in the region, as had been witnessed in other European regions. Resistant management strategies should be advocated to prolong the field efficacy of all MoA used against STB. Though no SDHI resistance-conferring mutations were detected, the possible existence of non-target site SDHI resistance should be considered for the design of resistance management strategies. Finally, we found a strain harboring a fourth transposon insertion in the promoter of the *MFS1* gene, which, however, does not display an MDR phenotype.
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